Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page was released. The update is likely to include minor edits to metadata or formatting rather than substantive changes to the study details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3. This reflects a minor metadata update to the ClinicalTrials.gov page without changing the study content.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.4.2 was added and the funding/operating-status notice was removed. The core study content and page structure remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.